Otsuka Holdings Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OTSKF research report →
Price Chart
About the company
Otsuka Holdings Co. , Ltd. engages in the management of its group companies which are in the pharmaceuticals business.
- CEO
- Makoto Inoue
- IPO
- 2012
- Employees
- 37,758
- HQ
- Tokyo, TY, JP
Get TickerSpark's AI analysis on OTSKF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $40.73B
- P/E
- 16.40
- Fwd P/E
- 0.12
- PEG
- 20.46
- P/S
- 2.53
- P/B
- 2.05
- EV/EBITDA
- 9.98
- Div Yield
- 1.35%
- Gross Margin
- 71.78%
- Op Margin
- 17.26%
- Net Margin
- 15.46%
- ROE
- 13.24%
- ROIC
- 9.52%
Latest fiscal year · YoY change
- Revenue
- $2.47T+6.1%
- Gross Profit
- $1.77T+6.1%
- Op Income
- $412.79B
- Net Income
- $363.47B+5.9%
- EPS
- $685.44+8.2%
- OCF Growth
- +13.9%
- FCF Growth
- +40.3%
- 52W High
- $77.53
- 52W Low
- $44.40
- 50D MA
- $68.24
- 200D MA
- $64.21
- Beta
- -0.05
- RSI (14)
- 99
- Avg Volume
- 62
No earnings-call transcripts are available for OTSKF yet.
- Free Float
- 76.7%
- Shares Outstanding
- 525.39M
- Float Shares
- 402.80M
Our OTSKF coverage
Recent articles, reports, and earnings notes.
No research on OTSKF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OTSKF report →Aristotle International Equity ADR WM Q1 2026 Contributors And Detractors
seekingalpha.com · May 7
Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
seekingalpha.com · Apr 10
Otsuka Holdings Co., Ltd. (OTSKY) Q4 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Feb 19
Otsuka (OTCMKTS:OTSKF) Trading Up 3% – Should You Buy?
defenseworld.net · Feb 12
US FDA approves Otsuka's kidney disease drug
reuters.com · Nov 25
Otsuka Corporation (OSUKF) Q1 FY2025 Earnings Call Transcript
seekingalpha.com · Aug 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.